These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 2544150

  • 1. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Irino S, Fujita J, Yamaji Y, Futami H, Hashimoto Y, Bungo M, Iuchi Y, Kamei M, Nakamura H, Hata Y.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
    [Abstract] [Full Text] [Related]

  • 2. [A pilot study of etoposide, split-dose cisplatin and THP in small cell lung cancer].
    Matsui Y, Satake N, Kusume K, Kado M, Ohshima S, Yamamoto Y, Ishida H, Matsubara Y, Ikeda S.
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2567-72. PubMed ID: 1660701
    [Abstract] [Full Text] [Related]

  • 3. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 4. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H, Kawatsu H, Saka H, Yamamoto M, Takagi E, Tsunekawa H, Kawachi H, Nagura E, Sakai S, Nishiwaki K.
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Adriamycin, cisplatin and etoposide combination chemotherapy in non-small cell lung cancer].
    Yamaji Y, Fujita J, Kamei M, Futami H, Hashimoto Y, Bungo M, Nakamura H, Hata Y, Shiotani T, Irino S.
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):601-6. PubMed ID: 1849390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 11. Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy Group.
    Bando H, Takishita Y, Ogura T, Sone S, Shimizu E, Nakayama T, Doi H, Kobayashi M.
    Jpn J Clin Oncol; 1991 Dec; 21(6):435-9. PubMed ID: 1666660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 Dec; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B, Thongprasert S.
    J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
    [Abstract] [Full Text] [Related]

  • 17. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H, Bando H, Takishita Y.
    Anticancer Res; 1995 Oct; 15(2):613-6. PubMed ID: 7539241
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Oct; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.